AzTrials
AzTrials

Muskuloskeletan PainExoskeletonEarNCT07919080

Ergonomic Evaluation of Microscopic Ear Surgery With Exoskeleton: A Single Site Non-blinded Study

An observational study of Muskuloskeletan Pain, run by East and North Hertfordshire NHS Trust at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn whether an exoskeleton system can reduce musculoskeletal strain and pain during microscopic ear surgery in ENT surgeons performing tympanomastoid and related microscopic ear procedures. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Muskuloskeletan Pain
How many people
60 participants
Where
1 siteUnited Kingdom
Study dates
24 Sep 2026to Sep 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population consists of ENT surgeons who routinely perform microscopic ear surgeries, including tympanomastoid procedures and hearing implant operations. Participants are clinicians working within the ENT department who are willing to undergo surface EMG monitoring and use the exoskeleton support system during live surgical procedures. Eligible participants must have experience in microscopic ear surgery and no pre-existing musculoskeletal conditions that would limit their ability to perform surgery or safely use the exoskeleton.

Who may be able to join

  • ENT surgeons who perform a range of microscopic ear surgery including tympanomastoid surgery and hearing implants.
  • Willing to participate with surface EMG (sEMG) monitoring and utilise the Ottobock exoskeleton

Who cannot join

  • Pre-existing musculoskeletal problems that limits procedures under microscope and tympanomastoid surgery
  • Unable to perform surgery using the exoskeleton

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ananth Vijendren, BM, FRCS (ORL-HNS), PhD contact

+441438288019

Ananth.vijendren1@nhs.net

Toral Odedra contact

toral.odedra@nhs.net

United Kingdom1 site, 1 recruiting
  • Lister Hospital, East and North Hertfordshire Teaching NHS Trust

    Stevenage, Hertfordshire, SG1 4AB

    Ananth Vijendren, +441438285421, ananth.vijendren1@nhs.net

    Recruiting

Other trials in United Kingdom

About this study

The goal of this observational study is to learn whether an exoskeleton system can reduce musculoskeletal strain and pain during microscopic ear surgery in ENT surgeons performing tympanomastoid and related microscopic ear procedures. The main questions it aims to answer are:

Does the use of an exoskeleton reduce musculoskeletal strain (measured via surface EMG activity) during surgery? Does the use of an exoskeleton reduce subjective pain scores in the neck, back, and shoulders during surgery?

Read more

Researchers will compare surgeries performed with the exoskeleton versus surgeries performed without the exoskeleton to see if it reduces strain, muscle activity, and pain levels.

Participants will:

Perform microscopic ear surgeries with and without the exoskeleton system Wear surface EMG electrodes on the neck, back, and shoulders to record muscle activity Provide subjective pain/strain scores at regular intervals (every 5 minutes) during surgery Follow standard surgical preparation and positioning procedures before data collection begins

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07919080
Study groupRoleWhat they receive
With ExoskeletonWith Exoskeleton: ENT surgeons performing microscopic ear surgery while wearing the exoskeleton support system. During procedures, participants will have surface EMG electrodes placed on the neck, back, and shoulders to measure muscle activity, and will report subjective pain/strain scores at regular intervals.
Without ExoskeletonWithout Exoskeleton: ENT surgeons performing microscopic ear surgery under standard conditions without the exoskeleton. The same protocol will be followed, including surface EMG monitoring and regular subjective pain/strain assessments, to allow comparison with the intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Visual Analogue Scale (VAS) Score for Musculoskeletal Strain

    Difference in participant-reported musculoskeletal strain during microscopic tympanomastoid surgery performed with and without the exoskeleton. Strain will be assessed using a Visual Analogue Scale (VAS) at 5-minute intervals throughout each operation.

    Measured: From the start of each operation to the end of the surgical procedure, with assessments every 5 minutes

  2. Difference in Surface Electromyography (sEMG) Amplitude (% Change From Rest)

    Difference in muscle activity, measured using surface electromyography (sEMG), during microscopic tympanomastoid surgery performed with and without the exoskeleton. Results will be expressed as percentage change from resting sEMG amplitude in the neck, shoulder and back muscles.

    Measured: From the start of each operation to the end of the surgical procedure.

  3. Difference in Maximum Surface Electromyography (sEMG) Amplitude

    Difference in maximum muscle activity, measured using surface electromyography (sEMG), during microscopic tympanomastoid surgery performed with and without the exoskeleton. Maximum sEMG amplitude will be assessed in the neck, shoulder and back muscles

    Measured: From the start of each operation to the end of the surgical procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2026
  2. Study start24 Sep 2026
  3. Primary completionSep 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07919080
Sponsor's protocol ID
RD2025-61
Acronym
ExoskeletonEar
Status last verified
Nov 2026
First submitted
28 Sep 2026
Last updated
5 Nov 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Muskuloskeletan Pain, run by East and North Hertfordshire NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ananth Vijendren, BM, FRCS (ORL-HNS), PhD (+441438288019, Ananth.vijendren1@nhs.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Visual Analogue Scale (VAS) Score for Musculoskeletal Strain (time frame: From the start of each operation to the end of the surgical procedure, with assessments every 5 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in